Cargando…
Bisdemethoxycurcumin (BDC)-Loaded H-Ferritin-Nanocages Mediate the Regulation of Inflammation in Alzheimer’s Disease Patients
Background: Bisdemethoxycurcumin (BDC) might be an inflammation inhibitor in Alzheimer’s Disease (AD). However, BDC is almost insoluble in water, poorly absorbed by the organism, and degrades rapidly. We thus developed a new nanoformulation of BDC based on H-Ferritin nanocages (BDC-HFn). Methods: We...
Autores principales: | Gagliardi, Stella, Truffi, Marta, Tinelli, Veronica, Garofalo, Maria, Pandini, Cecilia, Cotta Ramusino, Matteo, Perini, Giulia, Costa, Alfredo, Negri, Sara, Mazzucchelli, Serena, Bonizzi, Arianna, Sitia, Leopoldo, Busacca, Maria, Sevieri, Marta, Mocchi, Michela, Ricciardi, Alessandra, Prosperi, Davide, Corsi, Fabio, Cereda, Cristina, Morasso, Carlo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409287/ https://www.ncbi.nlm.nih.gov/pubmed/36012501 http://dx.doi.org/10.3390/ijms23169237 |
Ejemplares similares
-
Novel Bioengineering
Strategies to Improve Bioavailability
and In Vivo Circulation of H-Ferritin Nanocages
by Surface Functionalization
por: Sevieri, Marta, et al.
Publicado: (2023) -
Combined Method to Remove Endotoxins from Protein Nanocages for Drug Delivery Applications: The Case of Human Ferritin
por: Silva, Filippo, et al.
Publicado: (2021) -
Protein-Based Nanoparticles for the Imaging and Treatment of Solid Tumors: The Case of Ferritin Nanocages, a Narrative Review
por: Mainini, Francesco, et al.
Publicado: (2021) -
Selective Targeting of Cancer-Associated Fibroblasts by Engineered H-Ferritin Nanocages Loaded with Navitoclax
por: Sitia, Leopoldo, et al.
Publicado: (2021) -
Development of Tumor-Targeted Indocyanine Green-Loaded
Ferritin Nanoparticles for Intraoperative Detection of Cancers
por: Sitia, Leopoldo, et al.
Publicado: (2020)